Synthesis and Pharmacokinetics of 1α-Hydroxyvitamin D_3 Tritated at 22 and 23 Positins Showing High Spacific Radioactivity
スポンサーリンク
概要
- 論文の詳細を見る
A novel synthesis of a radioactive compound of 1α-hydroxyvitamin D_3 (1α OHD_3) (1) and its pharmacokinetics are described. Radioactive 1αOHD_3 tritiated at 22 and 23 positions ([22,23-^3H_4]1αOHD_3) (5) was prepared via key reactions of the reduction of acetylenic side chain in the ketone (12) with tritium gas in the presence of palladium-charcoal and the subsequent Wittig reaction with the A-ring synthon (16). [22,23-^3H_4]1αOHD_3 (5) showed high specific radioactivity (111.5 Ci/mmol) and was used successfully in pharmacokinetics studeies with rats. In the pharmacockinetics studies, the plasma concentration level of the active form of vitamin D_3,1α, 25-dihydroxyvitamin D_3 [1α, 25(OH)_2D_3], after oral or intravenous administration of [22,23-^3H_4]1αOHD_3 (5), showed longer half-life, lower maximum concentration, and lower area under the curve than those after treatment of 1α, 25(OH)_2D^3 tritiated at 26 and 27 positions (4). These results might suggest a beneficial therapeutic utility of 1αOHD_3 (1) over the treatment of 1α, 25(OH)_2D_3 (2).
- 公益社団法人日本薬学会の論文
- 2000-02-01
著者
-
KUBODERA Noboru
Chugai Pharmaceutical Co. Ltd.
-
Kubodera N
Chugai Pharmaceutical Co. Ltd. Tokyo Jpn
-
Stumpf Walter
International Institute Of Drug Distribution Cytopharmacology And Cytotoxicology
-
Kawase Akira
Chugai Pharmaceutical Co. Ltd.
-
ICHIKAWA Fumihiko
Chugai Pharmaceutical Co., Ltd.,
-
KOIKE Nobuo
Chugai Pharmaceutical Co., Ltd.,
-
KAMACHI Shinichi
Chugai Pharmaceutical Co., Ltd.,
-
NISHI Yasuho
Chugai Pharmaceutical Co., Ltd.,
-
Koike Nobuo
Chugai Pharmaceutical Co. Ltd.
-
Nishii Y
Chugai Pharmaceutical Co. Ltd.
-
Kamachi S
Chugai Pharmaceutical Co. Ltd.
-
Ichikawa Fumihiko
Chugai Pharmaceutical Co. Ltd.
-
Kubodera Noboru
Chugai Pharmaceutical Co.
-
KUBODERA Noboru
Chugai Pharmaceutical Co., Ltd.,
関連論文
- Synthetic Studies of Vitamin D Analogs. XXII.Synthesis and Antiproliferation Activity of Putative Metabolites of 1α, 25-Dihydroxy-22-oxavitamin D_3
- Isolation, Identification and Biological Activity of 24R,25-Dihydroxy-3-epi-vitamin D_3 : A Novel Metabolite of 24R, 25-Dihydroxyvitamin D_3 Produced in Rat Osteosarcoma Cells (UMR 106)
- In Vitro Biological Activities of a Series of 2β-Substituted Analogues of 1α, 25-Dihydroxyvitamin D_3
- Rapid Control of Transmembrane Calcium Influx by 1α, 25-Dihydroxyvitamin D_3 and Its Analogues in Rat Osteoblast-Like Cells
- Singly Dehydroxylated A-Ring Analogues of 19-Nor-1α, 25-dihydroxyvitamin D_3 and 19-Nor-22-oxa-1α, 25-dihydroxyvitamin D_3 : Novel Vitamin D_3 Analogues with Potent Transcriptional Activity but Extremely Low Affinity for Vitamin D Receptor
- Synthetic Studies of Vitamin D Analogs. XXIV. Synthesis of Active Vitamin D_3 Analogs Substituted at the 2β-Position and Their Preventive Effects on Bone Mineral Loss in Ovariectomized Rats
- New Metabolic Pathway of (24R)-24,25-Dihydroxyvitamin D_3 : Epimerization of the 3-Hydroxy Group
- Synthesis and Pharmacokinetics of 1α-Hydroxyvitamin D_3 Tritated at 22 and 23 Positins Showing High Spacific Radioactivity
- Isolation, Identification and Biological Activity of 24R,25-Dihydroxy-3-epi-vitamin D_3 : A Novel Metabolite of 24R, 25-Dihydroxyvitamin D_3 Produced in Rat Osteosarcoma Cells (UMR 106)